Schedule 13G ownership disclosure

AURIS MED HLDG AG

Security class unavailable · CUSIP: H0381L104

Event date: 2018-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,050,489
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-18-000948
Form type
SC 13G
Filer
Altamira Therapeutics Ltd.
CIK
CIK 1601936
Filed
Aug 10, 2018
Reporting period
Jul 25, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub